U.K. grants authorisation to Merek’s Anti Covid Pill
U.K. granted conditional authorisation to the first pill shown to successfully treat COVID-19 so far. It also is the first country to OK the treatment from drugmaker Merck, although it wasn’t immediately clear how quickly the pill would be available.
The pill was licensed for adults – 18 years and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease. The drug, known as molnupiravir, is intended to be taken twice a day for five days by people at home with mild to moderate covid19.
It has been authorised for use in people who have at least one risk factor for developing severe illness, including obesity, old age, diabetes and heart disease. Drug regulators in the United States and the European Union have already begun an evaluation of the drug.
